| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2024 | PBH Prestige Consumer Healthcare Inc. | Lombardi Ronald M.52 | Chief Executive Officer | Sell | 10,875 | $82.60 | $898,240.83 | -1.7% | +3.3% | -29.1% | |
| Nov 19, 2024 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 195,844 | $0.15 | $29,420.86 | - | - | - | |
| Nov 18, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Tessari Eben | Chief Operating Officer | Sell | 17,000 | $21.04 | $357,680.00 | -14.2% | -9.1% | +92.0% | |
| Nov 18, 2024 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 58,750 | $21.04 | $1,236,363.80 | -2.2% | +178.7% | +72.7% | |
| Nov 18, 2024 | IRWD Ironwood Pharmaceuticals Inc | Emany Sravan Kumar47 | SVP, COO And CFO | Sell | 11,001 | $4.08 | $44,884.08 | -3.4% | -50.2% | -22.6% | |
| Nov 18, 2024 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 10,000 | $359.21 | $3,592,071.27 | -31.3% | +3.8% | +32.7% | |
| Nov 18, 2024 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 472 | $19.42 | $9,166.24 | -8.4% | +178.7% | +72.7% | |
| Nov 18, 2024 | ASRT Assertio Holdings, Inc. | Mason Heather L49 | Director | Buy | 75,000 | $0.80 | $60,000.00 | +35.3% | -3.6% | -11.2% | |
| Nov 18, 2024 | IRWD Ironwood Pharmaceuticals Inc | Davis Andrew73 | SVP, Chief Business Officer | Sell | 5,360 | $4.08 | $21,868.80 | -1.8% | -50.2% | -22.6% | |
| Nov 18, 2024 | PBH Prestige Consumer Healthcare Inc. | Lombardi Ronald M.52 | Chief Executive Officer | Sell | 82,237 | $82.56 | $6,789,764.29 | -11.4% | +4.5% | -27.4% | |
| Nov 15, 2024 | TCNNF Trulieve Cannabis Corp. | Rivers Kim A. | Chairman And CEO | Buy | 7,400 | $6.65 | $49,210.00 | +0.4% | - | - | |
| Nov 15, 2024 | TLRY Tilray Brands, Inc. | Merton Carl A | Chief Financial Officer | Buy | 26,000 | $1.36 | $35,360.00 | New | -30.1% | -20.0% | |
| Nov 15, 2024 | TCNNF Trulieve Cannabis Corp. | Beshears Thad | Director | Buy | 7,500 | $6.65 | $49,875.00 | +0.3% | - | - | |
| Nov 15, 2024 | AMRX Amneal Pharmaceuticals, Inc. | Daly Jason B. | SVP, Chief Legal Officer | Sell | 43,657 | $8.61 | $375,886.77 | -76.2% | -6.6% | +37.4% | |
| Nov 15, 2024 | AAWH Ascend Wellness Holdings, Inc. | Millstreet Capital Management LLC | - | Sell | 325,000 | $0.45 | $145,047.50 | -1.5% | - | - | |
| Nov 15, 2024 | LNTH Lantheus Holdings, Inc. | Marshall Robert J. Jr.54 | CFO And Treasurer | Sell | 10,000 | $81.20 | $812,000.00 | -8.9% | +6.7% | -31.0% | |
| Nov 15, 2024 | RMTI Rockwell Medical, Inc. | Ravich Mark H | Director | Sell | 29,991 | $2.35 | $70,379.12 | -19.8% | -21.0% | -61.0% | |
| Nov 15, 2024 | ANIP Ani Pharmaceuticals Inc | Mutz Christopher | Head Of Rare Disease | Sell | 6,500 | $57.70 | $375,050.00 | -7.8% | +4.6% | +48.5% | |
| Nov 14, 2024 | ASRT Assertio Holdings, Inc. | O'Grady Brendan P. | CEO | Buy | 11,706 | $0.85 | $9,950.49 | New | +2.5% | -6.0% | |
| Nov 14, 2024 | LNTH Lantheus Holdings, Inc. | Blanchfield Paul54 | President | Sell | 2,000 | $79.65 | $159,300.00 | -2.0% | +1.6% | -34.4% | |
| Nov 14, 2024 | INIS International Isotopes Inc | Grosso Christopher G | Director | Buy | 401,117 | $0.03 | $12,033.51 | +64.2% | - | - | |
| Nov 14, 2024 | JUSHF Jushi Holdings Inc. | Mosier Michelle O | Chief Financial Officer | Buy | 25,166 | $0.40 | $10,098.10 | +12.7% | - | - | |
| Nov 14, 2024 | HIMS Hims & Hers Health, Inc. | Manuel Anja | Director | Buy | 5,000 | $26.45 | $132,259.60 | +125.0% | +122.3% | +77.4% | |
| Nov 14, 2024 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 4,000 | $0.17 | $685.00 | - | - | - | |
| Nov 13, 2024 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 142,886 | $29.93 | $4,276,608.76 | -14.2% | +57.9% | +30.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.